PML-RARA Regulated Adaptor Molecule 1 (PRAM1) (Middle Region) Peptide
Quick Overview for PML-RARA Regulated Adaptor Molecule 1 (PRAM1) (Middle Region) Peptide (ABIN8108400)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Purpose
- PRAM1 Peptide - middle region
-
Sequence
- HFQDRQPEDI PQVPDEIYEL YDDVEPRDDS SPSPKGRDEA PSVQQAARRP
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti- PRAM1 Antibody (ARP80503_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PRAM1 (PML-RARA Regulated Adaptor Molecule 1 (PRAM1))
-
Background
-
Background Information: The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha).
Alternative Symbols: PRAM-1, PML-RAR
-
Molecular Weight
- 78 kDa
-
Gene ID
- 84106
-
NCBI Accession
- NP_115528
-
UniProt
- Q96QH2
Target
-